Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan

Peritoneal Dialysis International

Volumn 33, Issue 6, 2013, Pages 671-678

  Kao, Tze Wah ^a,b   Chang, Yu Yin ^c   Chen, Pau Chung ^a,b   Hsu, Chih Cheng ^c   Chang, Yu Kang ^c,d   Chang, Yu Hung ^c   Lee, Lukas Jyuhn Hsiarn ^a,b,c   Wu, Kwan Dun ^a   Tsai, Tun Jun ^a   Wang, Jung Der ^b,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Hemodialysis; Lifetime cost

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; HEALTH CARE COST; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIFE EXPECTANCY; LIFESPAN; LIFETIME COST; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SURVIVAL; TAIWAN;

HEMODIALYSIS; LIFETIME COST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; TAIWAN; YOUNG ADULT;

EID: 84890405168     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00081     Document Type: Article

References (32)

1. United States, Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System (USRDS). 2011 Atlas of CKD & ESRD [Web resource]. Minneapolis, MN: USRDS; 2011. [Available at: http://www.usrds.org/atlas11.aspx; accessed 7March 2013]
2. Kontodimopoulos N, Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy 2008; 86:85-96.
3. Ranasinghe P, Perera YS, Makarim MF, Wijesinghe A, Wanigasuriya K. The costs in provision of haemodialysis in a developing country: a multi-centered study. BMC Nephrol 2011; 12:42.
4. Taiwan Society of Nephrology (TSN). History and Mission (Web page). Taipei, Taiwan: TSN; n.d. [Available at: http://www.tsn.org.tw/englishVersion/History.aspx; accessed 7 March 2013]
5. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 2008; 371:2173-82.
6. Yang WC, Hwang SJ on behalf of the Taiwan Society of Nephrology. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 2008; 23:3977-82.
7. Shiao CC, Kao TW, Hung KY, Chen YC, Wu MS, Chu TS, et al. Seven-year follow-up of peritoneal dialysis patients in Taiwan. Perit Dial Int 2009; 29:450-7.
8. Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD. Risks of kidney failure associated with consumption of herbal products containing mu tong or fangchi: a population-based case-control study. Am J Kidney Dis 2010; 55:507-18.
9. Government of Taiwan, Department of Health. Bureau of National Health Insurance [Web page]. Taipai, Taiwan: Department of Health; 2006. [Available online at: http://www.nhi.gov.tw/english/index.aspx; accessed 7March 2013]
10. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86:163-80.
11. Hwang JS, Tsauo JY, Wang JD. Estimation of expected quality adjusted survival by cross-sectional survey. Stat Med 1996; 15:93-102.
12. Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med 1999; 18:1627-40.
13. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM 2007; 100:97-105.
14. Kao TW, Huang JW, Hung KY, Chang YY, Chen PC, Yen CJ, et al. Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients. J Nephrol 2010; 23:677-82.
15. Hung MC, Yan YH, Fan PS, Lin MS, Chen CR, Kuo LC, et al. Estimation of quality-adjusted life expectancy in patients under prolonged mechanical ventilation. Value Health 2011; 14:347-53.
16. Huang CC. Treatment targets for diabetic patients on peritoneal dialysis: any evidence? Perit Dial Int 2007; 27(Suppl 2):S176-9.
17. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; 18:2125-34.
18. Yang WC, Hwang SJ, Chiang SS, Chen HF, Tsai ST. The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan. Diabetes Res Clin Pract 2001; 54(Suppl 1):S47-54.
19. Berger A, Edelsberg J, Inglese GW, Bhattacharyya SK, Oster G. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care 2009; 15:509-18.
20. Sennfält K, Magnusson M, Carlsson P. Comparison of hemodialysis and peritoneal dialysis-a cost-utility analysis. Perit Dial Int 2002; 22:39-47.
21. Pacheco A, Saffie A, Torres R, Tortella C, Llanos C, Vargas D, et al. Cost/utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int 2007; 27:359-63.
22. Gupta A, Gupta P, Biyani M. Targeted therapies in diabetic nephropathy: an update. J Nephrol 2011; 24:686-95.
23. Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, Mussap M. Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol 2006; 17(Suppl 2):S86-9.
24. Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant 2012; 27:1847-54.
25. Slade H, Williams SM, Manning PJ, Walker RJ. High-risk diabetic nephropathy patients: the outcome of evidence-based clinical practice in an outpatient clinic. Diabetes Res Clin Pract 2011; 92:356-60.
26. Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med 2007; 120:1063-70.
27. Warmington V. A home visit program for CAPD. Perit Dial Int 1996; 16(Suppl 1):S475-8.
28. Nayak KS, Sinoj KA, Subhramanyam SV, Mary B, Rao NVV. Our experience of home visits in city and rural areas. Perit Dial Int 2007; 27(Suppl 2):S27-31.
29. Helanterä I, Haapio M, Koskinen P, Grönhagen-Riska C, Finne P. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland. Am J Kidney Dis 2012; 59:700-6.
30. Thodis ED, Oreopoulos DG. Home dialysis first: a new paradigm for new ESRD patients. J Nephrol 2011; 24:398-404.
31. Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007; 10:61-72.
32. Villa G, Rodríguez-Carmona A, Fernández-Ortiz L, Cuervo J, Rebollo P, Otero A, et al. Cost analysis of the Spanish renal replacement therapy programme. Nephrol Dial Transplant 2011; 26:3709-14.